Literature DB >> 31710255

Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis.

Marco Cerrano1,2, Valérie Seegers3, Emmanuel Raffoux1, Florence Rabian1, Marie Sébert4, Raphael Itzykson1, Virginie Lemiale5, Lionel Adès4, Nicolas Boissel6, Hervé Dombret1, Elie Azoulay5, Etienne Lengliné1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31710255     DOI： 10.1080/10428194.2019.1683735

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.

Authors:  Sofiane Fodil; Sylvie Chevret; Camille Rouzaud; Sandrine Valade; Florence Rabian; Eric Mariotte; Emmanuel Raffoux; Raphael Itzykson; Nicolas Boissel; Marie Sébert; Lionel Adès; Lara Zafrani; Elie Azoulay; Etienne Lengliné
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

2.  Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis.

Authors:  Nathan Mottal; Nahema Issa; Pierre-Yves Dumas; Fabrice Camou; Mathieu Sauvezie; Francois-Xavier Gros; Titouan Cazaubiel; Gaelle Mourissoux; Harmony Leroy; Arnaud Pigneux; Olivier Guisset; Thibaut Leguay
Journal:  J Hematol       Date:  2020-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.